Legal Question: how can pharmaceutical companies produce opiate derivatives but not triptymines? The federal analogue act prohibits drugs which are related (through structure or performance) to scheduled substances, which explains why drug companies won't produce triptymine analogues (4-HO-MET for instance). But then how do pharmaceutical companies get away with producing what could absolutely be considered analogues of heroin (fentanyl for instance)?